Fexofenadina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fexofenadina" in Italian language version.

refsWebsite

Global rank Italian rank

18nih.gov

4^th place

9^th place

13oadoi.org

799^th place

22^nd place

13doi.org

2^nd place

7^th place

doi.org

dx.doi.org

T. Russell, M. Stoltz; S. Weir, Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers., in Clin Pharmacol Ther, vol. 64, n. 6, Dec 1998, pp. 612-21, DOI:10.1016/S0009-9236(98)90052-2, PMID 9871426.
G. Lappin, Y. Shishikura; R. Jochemsen; RJ. Weaver; C. Gesson; B. Houston; B. Oosterhuis; OJ. Bjerrum; M. Rowland; C. Garner, Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability., in Eur J Pharm Sci, vol. 40, n. 2, maggio 2010, pp. 125-31, DOI:10.1016/j.ejps.2010.03.009, PMID 20307657.
DI. Bernstein, WF. Schoenwetter; RA. Nathan; W. Storms; R. Ahlbrandt; J. Mason, Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 79, n. 5, Nov 1997, pp. 443-8, DOI:10.1016/S1081-1206(10)63041-4, PMID 9396979.
C. Bachert, A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis., in Clin Ther, vol. 31, n. 5, maggio 2009, pp. 921-44, DOI:10.1016/j.clinthera.2009.05.017, PMID 19539095.
AK. Thompson, AF. Finn; WF. Schoenwetter, Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria., in J Am Acad Dermatol, vol. 43, 1 Pt 1, Jul 2000, pp. 24-30, DOI:10.1067/mjd.2000.104680, PMID 10863219.
DF. Graft, DI. Bernstein; A. Goldsobel; EO. Meltzer; J. Portnoy; J. Long, Safety of fexofenadine in children treated for seasonal allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 87, n. 1, Jul 2001, pp. 22-6, DOI:10.1016/S1081-1206(10)62317-4, PMID 11476456.
EO. Meltzer, P. Scheinmann; JE. Rosado Pinto; C. Bachert; G. Hedlin; U. Wahn; AF. Finn; E. Ruuth, Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies., in Pediatr Allergy Immunol, vol. 15, n. 3, Jun 2004, pp. 253-60, DOI:10.1111/j.1399-3038.2004.00167.x, PMID 15209959.
H. Milgrom, B. Kittner; R. Lanier; FC. Hampel, Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old., in Ann Allergy Asthma Immunol, vol. 99, n. 4, Oct 2007, pp. 358-63, DOI:10.1016/S1081-1206(10)60553-4, PMID 17941284.
FC. Hampel, B. Kittner; JH. van Bavel, Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 99, n. 6, Dec 2007, pp. 549-54, DOI:10.1016/S1081-1206(10)60385-7, PMID 18219837.
AV. Kamath, M. Yao; Y. Zhang; S. Chong, Effect of fruit juices on the oral bioavailability of fexofenadine in rats., in J Pharm Sci, vol. 94, n. 2, Feb 2005, pp. 233-9, DOI:10.1002/jps.20231, PMID 15570603.
GK. Dresser, DG. Bailey; BF. Leake; UI. Schwarz; PA. Dawson; DJ. Freeman; RB. Kim, Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine., in Clin Pharmacol Ther, vol. 71, n. 1, Jan 2002, pp. 11-20, DOI:10.1067/mcp.2002.121152, PMID 11823753.
GK. Dresser, RB. Kim; DG. Bailey, Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides., in Clin Pharmacol Ther, vol. 77, n. 3, Mar 2005, pp. 170-7, DOI:10.1016/j.clpt.2004.10.005, PMID 15735611.
DG. Bailey, Fruit juice inhibition of uptake transport: a new type of food-drug interaction., in Br J Clin Pharmacol, vol. 70, n. 5, Nov 2010, pp. 645-55, DOI:10.1111/j.1365-2125.2010.03722.x, PMID 21039758.

nih.gov

ncbi.nlm.nih.gov

T. Russell, M. Stoltz; S. Weir, Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers., in Clin Pharmacol Ther, vol. 64, n. 6, Dec 1998, pp. 612-21, DOI:10.1016/S0009-9236(98)90052-2, PMID 9871426.
DK. Robbins, MA. Castles; DJ. Pack; VO. Bhargava; SJ. Weir, Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers., in Biopharm Drug Dispos, vol. 19, n. 7, Oct 1998, pp. 455-63, PMID 9818712.
G. Lappin, Y. Shishikura; R. Jochemsen; RJ. Weaver; C. Gesson; B. Houston; B. Oosterhuis; OJ. Bjerrum; M. Rowland; C. Garner, Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability., in Eur J Pharm Sci, vol. 40, n. 2, maggio 2010, pp. 125-31, DOI:10.1016/j.ejps.2010.03.009, PMID 20307657.
EA. Bronsky, CJ. Falliers; HB. Kaiser; R. Ahlbrandt; JM. Mason, Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies., in Allergy Asthma Proc, vol. 19, n. 3, pp. 135-41, PMID 9642436.
DI. Bernstein, WF. Schoenwetter; RA. Nathan; W. Storms; R. Ahlbrandt; J. Mason, Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 79, n. 5, Nov 1997, pp. 443-8, DOI:10.1016/S1081-1206(10)63041-4, PMID 9396979.
C. Bachert, A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis., in Clin Ther, vol. 31, n. 5, maggio 2009, pp. 921-44, DOI:10.1016/j.clinthera.2009.05.017, PMID 19539095.
K. Kulthanan, P. Gritiyarangsan; C. Sitakalin; S. Charuwichitratana; W. Korkij; K. Aunhachoke; P. Janjumratsang; S. Jiamton; M. Kuntiranont; J. Krisadapong; N. Gherunpong, Multicenter study of the efficacy and safety of fexofenadine 60 mg twice daily in 108 Thai patients with chronic idiopathic urticaria., in J Med Assoc Thai, vol. 84, n. 2, Feb 2001, pp. 153-9, PMID 11336071.
AK. Thompson, AF. Finn; WF. Schoenwetter, Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria., in J Am Acad Dermatol, vol. 43, 1 Pt 1, Jul 2000, pp. 24-30, DOI:10.1067/mjd.2000.104680, PMID 10863219.
M. Kawashima, S. Harada; T. Tango, Review of fexofenadine in the treatment of chronic idiopathic urticaria., in Int J Dermatol, vol. 41, n. 10, Oct 2002, pp. 701-6, PMID 12390200.
DF. Graft, DI. Bernstein; A. Goldsobel; EO. Meltzer; J. Portnoy; J. Long, Safety of fexofenadine in children treated for seasonal allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 87, n. 1, Jul 2001, pp. 22-6, DOI:10.1016/S1081-1206(10)62317-4, PMID 11476456.
EO. Meltzer, P. Scheinmann; JE. Rosado Pinto; C. Bachert; G. Hedlin; U. Wahn; AF. Finn; E. Ruuth, Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies., in Pediatr Allergy Immunol, vol. 15, n. 3, Jun 2004, pp. 253-60, DOI:10.1111/j.1399-3038.2004.00167.x, PMID 15209959.
U. Wahn, EO. Meltzer; AF. Finn; ML. Kowalski; P. Decosta; G. Hedlin; P. Scheinmann; C. Bachert; JE. Rosado Pinto; C. Baena-Cagnani; P. Potter, Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis., in J Allergy Clin Immunol, vol. 111, n. 4, Apr 2003, pp. 763-9, PMID 12704355.
H. Milgrom, B. Kittner; R. Lanier; FC. Hampel, Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old., in Ann Allergy Asthma Immunol, vol. 99, n. 4, Oct 2007, pp. 358-63, DOI:10.1016/S1081-1206(10)60553-4, PMID 17941284.
FC. Hampel, B. Kittner; JH. van Bavel, Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 99, n. 6, Dec 2007, pp. 549-54, DOI:10.1016/S1081-1206(10)60385-7, PMID 18219837.
AV. Kamath, M. Yao; Y. Zhang; S. Chong, Effect of fruit juices on the oral bioavailability of fexofenadine in rats., in J Pharm Sci, vol. 94, n. 2, Feb 2005, pp. 233-9, DOI:10.1002/jps.20231, PMID 15570603.
GK. Dresser, DG. Bailey; BF. Leake; UI. Schwarz; PA. Dawson; DJ. Freeman; RB. Kim, Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine., in Clin Pharmacol Ther, vol. 71, n. 1, Jan 2002, pp. 11-20, DOI:10.1067/mcp.2002.121152, PMID 11823753.
GK. Dresser, RB. Kim; DG. Bailey, Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides., in Clin Pharmacol Ther, vol. 77, n. 3, Mar 2005, pp. 170-7, DOI:10.1016/j.clpt.2004.10.005, PMID 15735611.
DG. Bailey, Fruit juice inhibition of uptake transport: a new type of food-drug interaction., in Br J Clin Pharmacol, vol. 70, n. 5, Nov 2010, pp. 645-55, DOI:10.1111/j.1365-2125.2010.03722.x, PMID 21039758.

oadoi.org

T. Russell, M. Stoltz; S. Weir, Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers., in Clin Pharmacol Ther, vol. 64, n. 6, Dec 1998, pp. 612-21, DOI:10.1016/S0009-9236(98)90052-2, PMID 9871426.
G. Lappin, Y. Shishikura; R. Jochemsen; RJ. Weaver; C. Gesson; B. Houston; B. Oosterhuis; OJ. Bjerrum; M. Rowland; C. Garner, Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability., in Eur J Pharm Sci, vol. 40, n. 2, maggio 2010, pp. 125-31, DOI:10.1016/j.ejps.2010.03.009, PMID 20307657.
DI. Bernstein, WF. Schoenwetter; RA. Nathan; W. Storms; R. Ahlbrandt; J. Mason, Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 79, n. 5, Nov 1997, pp. 443-8, DOI:10.1016/S1081-1206(10)63041-4, PMID 9396979.
C. Bachert, A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis., in Clin Ther, vol. 31, n. 5, maggio 2009, pp. 921-44, DOI:10.1016/j.clinthera.2009.05.017, PMID 19539095.
AK. Thompson, AF. Finn; WF. Schoenwetter, Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria., in J Am Acad Dermatol, vol. 43, 1 Pt 1, Jul 2000, pp. 24-30, DOI:10.1067/mjd.2000.104680, PMID 10863219.
DF. Graft, DI. Bernstein; A. Goldsobel; EO. Meltzer; J. Portnoy; J. Long, Safety of fexofenadine in children treated for seasonal allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 87, n. 1, Jul 2001, pp. 22-6, DOI:10.1016/S1081-1206(10)62317-4, PMID 11476456.
EO. Meltzer, P. Scheinmann; JE. Rosado Pinto; C. Bachert; G. Hedlin; U. Wahn; AF. Finn; E. Ruuth, Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies., in Pediatr Allergy Immunol, vol. 15, n. 3, Jun 2004, pp. 253-60, DOI:10.1111/j.1399-3038.2004.00167.x, PMID 15209959.
H. Milgrom, B. Kittner; R. Lanier; FC. Hampel, Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old., in Ann Allergy Asthma Immunol, vol. 99, n. 4, Oct 2007, pp. 358-63, DOI:10.1016/S1081-1206(10)60553-4, PMID 17941284.
FC. Hampel, B. Kittner; JH. van Bavel, Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis., in Ann Allergy Asthma Immunol, vol. 99, n. 6, Dec 2007, pp. 549-54, DOI:10.1016/S1081-1206(10)60385-7, PMID 18219837.
AV. Kamath, M. Yao; Y. Zhang; S. Chong, Effect of fruit juices on the oral bioavailability of fexofenadine in rats., in J Pharm Sci, vol. 94, n. 2, Feb 2005, pp. 233-9, DOI:10.1002/jps.20231, PMID 15570603.
GK. Dresser, DG. Bailey; BF. Leake; UI. Schwarz; PA. Dawson; DJ. Freeman; RB. Kim, Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine., in Clin Pharmacol Ther, vol. 71, n. 1, Jan 2002, pp. 11-20, DOI:10.1067/mcp.2002.121152, PMID 11823753.
GK. Dresser, RB. Kim; DG. Bailey, Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides., in Clin Pharmacol Ther, vol. 77, n. 3, Mar 2005, pp. 170-7, DOI:10.1016/j.clpt.2004.10.005, PMID 15735611.
DG. Bailey, Fruit juice inhibition of uptake transport: a new type of food-drug interaction., in Br J Clin Pharmacol, vol. 70, n. 5, Nov 2010, pp. 645-55, DOI:10.1111/j.1365-2125.2010.03722.x, PMID 21039758.